Tesar V - Search Results

1

Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients.

Kalousová M, Jáchymová M, Germanová A, Kubena AA, Tesar V, Zima T. Kalousová M, et al. Among authors: tesar v. Kidney Blood Press Res. 2010;33(1):30-6. doi: 10.1159/000285845. Epub 2010 Feb 23. Kidney Blood Press Res. 2010. PMID: 20185929 Free article.

2

Soluble cytokine receptors in renal vasculitis and lupus nephritis.

Tesar V, Jirsa M Jr, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J. Tesar V, et al. Med Sci Monit. 2002 Jan;8(1):BR24-9. Med Sci Monit. 2002. PMID: 11782670

3

Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome.

Tesar V, Zima T, Jirsa M Jr, Crkovská J, Stípek S, Vernerová Z, Seráková M. Tesar V, et al. Med Sci Monit. 2002 Feb;8(2):BR69-74. Med Sci Monit. 2002. PMID: 11859270

4

Endothelial nitric oxide synthase affects the progression of autosomal dominant polycystic kidney disease.

Reiterová J, Merta M, Tesar V, Stekrová J. Reiterová J, et al. Among authors: tesar v. Kidney Blood Press Res. 2002;25(2):87-90. doi: 10.1159/000063513. Kidney Blood Press Res. 2002. PMID: 12077489

5

Pathobiochemistry of nephrotic syndrome.

Tesar V, Zima T, Kalousová M. Tesar V, et al. Adv Clin Chem. 2003;37:173-218. doi: 10.1016/s0065-2423(03)37009-x. Adv Clin Chem. 2003. PMID: 12619708 Review.

6

Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis patients.

Kalousová M, Zima T, Tesar V, Sulková S, Fialová L. Kalousová M, et al. Among authors: tesar v. Kidney Int Suppl. 2003 May;(84):S62-4. doi: 10.1046/j.1523-1755.63.s84.19.x. Kidney Int Suppl. 2003. PMID: 12694311 Free article. Review.

7

Advanced glycation end products in hemodialyzed patients with diabetes mellitus correlate with leptin and leptin/body fat ratio.

Kalousová M, Sulková S, Zima T, Deppisch R, Beck W, Bednárová sV, Fortová M, Tesar V. Kalousová M, et al. Among authors: tesar v. Ren Fail. 2003 Mar;25(2):277-86. doi: 10.1081/jdi-120018728. Ren Fail. 2003. PMID: 12739834

8

Antiphospholipid antibodies in patients with lupus nephritis.

Fialová L, Zima T, Tesar V, Mikulíková L, Malbohan IM, Merta M, Certíková V. Fialová L, et al. Among authors: tesar v. Ren Fail. 2003 Sep;25(5):747-58. doi: 10.1081/jdi-120024290. Ren Fail. 2003. PMID: 14575283

9

Glycoxidation and inflammation in chronic haemodialysis patients.

Kalousová M, Sulková S, Fialová L, Soukupová J, Malbohan IM, Spacek P, Braun M, Mikulíková L, Fortová M, Horejsí M, Tesar V, Zima T. Kalousová M, et al. Among authors: tesar v. Nephrol Dial Transplant. 2003 Dec;18(12):2577-81. doi: 10.1093/ndt/gfg404. Nephrol Dial Transplant. 2003. PMID: 14605280

10

Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats.

Dvorák P, Kramer HJ, Bäcker A, Malý J, Kopkan L, Vanecková I, Vernerová Z, Opocenský M, Tesar V, Bader M, Ganten D, Janda J, Cervenka L. Dvorák P, et al. Among authors: tesar v. Kidney Blood Press Res. 2004;27(4):248-58. doi: 10.1159/000080052. Epub 2004 Aug 2. Kidney Blood Press Res. 2004. PMID: 15286437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

593 results

Search Page

Filters